Eligo Bioscience
2 employees
Biotech
Series B · $52.3M
Company details
Team Size2
IndustryBiotech
Funding
Total raised
$52.3M
Last stage
Series B
Investors
Seventure Partners
Total raised
$52.3M
Last stage
Series B
Investors
David Bikard
Professor at Institut Pasteur, Head of the Synthetic Biology Lab. CRISPR bacterial editing co-inventor.
Luciano Marraffini
Professor at The Rockefeller University, HHMI Investigator, CRISPR seminal inventor, and co-founder of Intellia Therapeutics.
Xavier Duportet
PhD in Synthetic Biology (MIT/INRIA). Co-founded Eligo Bioscience in 2014. MIT TR35, Forbes 30 Under 30, World Economic Forum Technology Pioneer, and Termeer Fellow.
LinkedInNo applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.